Hlee Lor
Physician Assistant · Sacramento, CANPI 1639804818
Payments from drug & device makers
Across 313 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$838
- Novo Nordisk$588
- Lilly USA, LLC$525
- Bayer$411
- Tandem Diabetes Care, Inc.$367
- AstraZeneca$365
- plus $4K from 30 others
What the payments were for
- Food & beverage$6,643100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 45 | $838 |
| Novo Nordisk | 32 | $588 |
| Lilly USA, LLC | 21 | $525 |
| Bayer | 17 | $411 |
| Tandem Diabetes Care, Inc. | 13 | $367 |
| AstraZeneca(2 entities) | 14 | $365 |
| Sanofi | 24 | $347 |
| Mannkind Corporation | 17 | $314 |
| Corcept Therapeutics | 11 | $307 |
| Sanofi-aventis U.S. LLC | 15 | $228 |
| Xeris Pharmaceuticals, Inc. | 13 | $202 |
| Regeneron Healthcare Solutions, Inc. | 6 | $201 |
| Medtronic | 11 | $194 |
| GSK | 7 | $193 |
| Boehringer Ingelheim | 11 | $172 |
| Almatica Pharma LLC | 10 | $154 |
| Antares Pharma, Inc. | 5 | $129 |
| Novartis | 4 | $117 |
| Intra-sana Laboratories | 4 | $113 |
| Dexcom, Inc. | 4 | $110 |
| Radius Health, Inc. | 4 | $90 |
| BETA Bionics, Inc. | 4 | $89 |
| Madrigal Pharmaceuticals | 2 | $85 |
| Ascendis Pharma Endocrinology Inc | 3 | $83 |
| Sequel Med Tech, LLC | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Inspire Medical Systems, Inc. | 1 | $50 |
| Abbott | 2 | $50 |
| Verity Pharmaceuticals Inc. | 2 | $38 |
| Tolmar, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Pfizer | 1 | $27 |
| Alvogen Inc | 1 | $26 |
| Insulet Corporation | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Cequr Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,643 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StrensiqAsfotase Alfa | 12 | $628,260 |
| OzempicSemaglutide | 281 | $369,439 |
| JardianceEmpagliflozin | 89 | $142,311 |
| MounjaroTirzepatide | 81 | $100,291 |
| KerendiaFinerenone | 32 | $50,294 |
| FarxigaDapagliflozin Propanediol | 30 | $30,844 |
| TrulicityDulaglutide | 24 | $26,536 |
| RybelsusSemaglutide | 20 | $24,091 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 16 | $17,104 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $12,075 |
| Humalog Kwikpen U-100Insulin Lispro | 27 | $10,952 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 14 | $10,865 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $9,128 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $7,747 |
| Testosterone | 25 | $4,299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaStrensiq, Farxiga | $365 | $659,10442 claims |
| Novo NordiskOzempic, Rybelsus | $588 | $393,530301 claims |
| Boehringer IngelheimJardiance | $172 | $142,31189 claims |
| Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro | $525 | $128,387117 claims |
| BayerKerendia | $411 | $50,29432 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Sacramento
- Franklin ClineSacramento$458K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.